Panacea Life Sciences, Inc. Expands Premium Skincare Line with Two New, Purpose-Driven CBD and CBG Products
GOLDEN, CO / ACCESSWIRE / March 2, 2022 / Panacea Life Sciences, Inc. (OTCQB:PLSH), (the "Company"), a Colorado, USA-based biotech...
News
SPO Global Inc. Announces Strategic Cooperation Plan
Shandong, China, March 02, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today...
HealthEquity Named One of the Nation’s Top Workplaces
Receives recognition after employees give HealthEquity high marks in national independent surveyDRAPER, Utah, March 02, 2022 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”),...
Capricor Therapeutics Names Dr. Daniel Paulson as Vice President of Clinical Development
Dr. Paulson Will Lead Clinical Efforts Focused on Capricor’s Late-Stage Cell Therapy Program and its Expanding Exosome Platform--SAN DIEGO, March...
Avra, Inc., Operating as Springs Rejuvenation (AVRN), Expands Atlanta Operations
ATLANTA, GA, March 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Avra, Inc. (OTC PINK: AVRN), operating as Springs Rejuvenation, (“Spring”), a...
Shattuck Labs Announces Participation in Upcoming March Conferences
AUSTIN, TX and DURHAM, NC, March 02, 2022 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology...
Hillstream BioPharma R&D Day Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Action, Targeting Drug Resistant and Devastating Cancers
HSB-1216’s active moiety in clinical pilot study produced a 71% response rate in TNBC and epithelial carcinomasHSB-1216 was recently granted...
Yield10 Bioscience to Announce Fourth Quarter and Full Year 2021 Financial Results and Host a Conference Call on Wednesday, March 9, 2022
WOBURN, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,...
ICU Medical, Inc. to Participate at the Raymond James 43rd Annual Institutional Investors Conference
SAN CLEMENTE, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and...
SCYNEXIS to Participate in Upcoming Scientific Conferences and Events
JERSEY CITY, N.J., March 02, 2022 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...
Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting
Stella Diagnostics Designated as a Semi-Finalist for SAGES Shark Tank 2022Stella Diagnostics and Collaborators to Give a Clinical Science Data...
Artelo Biosciences Receives Notice of Allowance for Method-of-Use Patent in the United States for ART12.11, a Proprietary Cocrystal of Cannabidiol
SOLANA BEACH, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating...
Cura Foundation and Sanford Health Win Two Awards in the Inaugural Anthem Awards
The Cura Foundation and Sanford Health are honored to be recognized as Silver Winners for Best Nonprofit Campaign and Best...
InnerScope Hearing Technologies (OTC: INND) Offers Hearing Products on Walmart Canada’s Flagship Online Store – Walmart.ca
InnerScope Offers its HearingAssist and iHear Branded Hearing Products and Related Supplies to more than 1.5 Million Customers that Visit...
Teknova to Report Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022
HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents...
Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism
– Notice of allowance received by Company’s licensor, The University of Sheffield (UK) bolsters intellectual property of AEZS-150 in development...
Codex DNA to Report Fourth Quarter 2021 Financial Results on Tuesday, March 22, 2022
SAN DIEGO, March 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology...
Catalyst Pharmaceuticals Further Strengthens FIRDAPSE® U.S. Patent Portfolio
Three New Patents Covering Additional Patient Amifampridine Metabolizer Types have been Allowed and will Issue in March 2022 Reinforces and...
F-star Therapeutics to Host Fourth Quarter and Full-Year 2021 Financial Results Conference Call on March 14, 2022
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company...
Sensus Healthcare Sells its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash
Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion BOCA RATON, Fla., March...